BlueCrest Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-216,643
Closed -$20.6M 1701
2018
Q3
$20.6M Buy
216,643
+140,302
+184% +$12M 0.55% 19
2018
Q2
$5.89M Buy
76,341
+9,191
+14% +$690K 0.15% 149
2018
Q1
$4.64M Buy
67,150
+47,557
+243% +$3.63M 0.14% 141
2017
Q4
$1.46M Sell
19,593
-37,707
-66% -$2.41M 0.04% 317
2017
Q3
$3.63M Buy
57,300
+51,358
+864% +$3.19M 0.15% 170
2017
Q2
$379K Sell
5,942
-11,926
-67% -$749K 0.01% 643
2017
Q1
$1.18M Sell
17,868
-17,255
-49% -$1.19M 0.06% 295
2016
Q4
$2.42M Buy
35,123
+29,977
+583% +$2.15M 0.13% 224
2016
Q3
$363K Sell
5,146
-16,003
-76% -$1.2M 0.01% 588
2016
Q2
$1.6M Sell
21,149
-734
-3% -$54K 0.07% 282
2016
Q1
$1.5M Buy
+21,883
New +$1.57M 0.09% 290
2015
Q4
Sell
-44,036
Closed -$3.56M 1278
2015
Q3
$3.56M Buy
+44,036
New +$3.84M 0.12% 172

Other funds holding ESRX

BlueCrest Capital Management's ESRX Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 216,643 shares — an estimated $20.6M sold.

BlueCrest Capital Management first reported a position in ESRX in Q3 2015 and held it in 12 quarters. The position peaked at $20.6M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 216,643 Express Scripts Holding Company shares in Q4 2018, an estimated $20.6M.
  • BlueCrest Capital Management first reported a position in Express Scripts Holding Company in Q3 2015 and held it in 12 quarters.
  • BlueCrest Capital Management's Express Scripts Holding Company position peaked at $20.6M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.